Bulletin from the Extraordinary General Meeting of Diagonal Bio AB on 17 January 2025 January 18, 2025
Diagonal Bio enters into a strategic partnership with Daniel Redén at StallZet to enhance commercialisation plans December 23, 2024
Diagonal Bio announces pilot test of LAMPlify® at Norwegian University of Life Sciences October 25, 2024
Diagonal Bio announces successful external validation of LAMPlify® for viruses in pigs October 11, 2024
Diagonal Bio AB’s warrant exercise registered at the Swedish Companies Registration Office October 2, 2024